CELLORIGIN BIOTECH
CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.
CELLORIGIN BIOTECH
Industry:
Biotechnology
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.en.cell-origin.com
Status:
Active
Contact:
178-0581-5679
Email Addresses:
[email protected]
Total Funding:
15.71 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Mobile Non Scaleable Content Euro Pound Sterling Japanese Yen Baidu Analytics Bootcss
Similar Organizations
Everna
Everna is a biotech company developing novel therapeutics.
Founder
Investors List
EFung Capital
EFung Capital investment in Venture Round - CellOrigin Biotech
Jifeng Ventures
Jifeng Ventures investment in Venture Round - CellOrigin Biotech
Yinxinggu Capital
Yinxinggu Capital investment in Venture Round - CellOrigin Biotech
Kunlun Capital
Kunlun Capital investment in Venture Round - CellOrigin Biotech
KUNLUN
KUNLUN investment in Venture Round - CellOrigin Biotech
Official Site Inspections
http://www.en.cell-origin.com
- Host name: server-3-167-112-48.iad55.r.cloudfront.net
- IP address: 3.167.112.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "CellOrigin Biotech"
CellOrigin Technology (Hangzhou) Co., Ltd.
Mature stem cell reprogramming technology High-efficiency stem cell gene modification technology Stem cell directed differentiation technologySee details»
Company Profile_CellOrigin Technology (Hangzhou) Co., Ltd.
CellOrigin Biotech (Hangzhou) Co., Ltd. is committed to the development of genetically engineered pluripotent stem cells (iPSC) derived immune cell therapies (such as …See details»
Contact Us_CellOrigin Technology (Hangzhou) Co., Ltd.
Address. R&D Center: 2nd floor, Building 4, Future Science and Technology City Health Valley Phase II, No. 110 Liuze Street, Yuhang District, Hangzhou Production base: 11-12 floor, …See details»
CellOrigin Biotech - Crunchbase Company Profile
IPSC-derived Innate Immune Cell Platform: A platform focused on creating immune cell therapies from iPSCs, including macrophages and NK cells, for …See details»
Cellorigin Biotechnology (Hangzhou) Co., Ltd. - Drug pipelines, …
Explore Cellorigin Biotechnology (Hangzhou) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news, Disease Domain:Neoplasms, Hemic and …See details»
CellOrigin Biotech Company Profile: Overview and Full News Analysis
En.cell-origin.com. Overview: CellOrigin Biotech. CellOrigin Biotech, located in Zhejiang, is a biotechnology company specializing in innovative technologies for efficient iPSC differentiation …See details»
CellOrigin Biotech Overview | SignalHire Company Profile
Organization Website: en.cell-origin.com : CellOrigin Biotech industries Biotech: Headquarters Location: Hangzhou, Zhejiang, CN Hangzhou, Zhejiang, CN : CellOrigin Biotech Employees …See details»
CellOrigin Biotech - PitchBook
CellOrigin Biotech General Information Description. Developer of immune cell technology and therapy to treat solid tumors. The company focuses on the research and development of iPSC-derived immune cells, gene manipulated …See details»
CellOrigin Biotech - VentureRadar
The founders are experienced leaders from Hengrui Pharma, AISO BIO, Harvard University and Zhejiang University. We apply metabolomics & transcriptomics analysis, functional CRISPR …See details»
CellOrigin - Overview, News & Similar companies | ZoomInfo.com
Dec 19, 2023 en.prnasia.com . CellOrigin Biotech Announces Global Strategic Collaboration ... Sep 26, 2022. ... +86 17805815679 Website: www.cell-origin.com What does CellOrigin do? …See details»
CellOrigin - Products, Competitors, Financials, Employees, …
CellOrigin is a biotech company with a focus on induced pluripotent stem cell (iPSC)-derived innate immune cells and their applications in cancer immunotherapies. It offers a flagship …See details»
CellOrigin - Company Profile - Tracxn
CellOrigin - Developer of immune cell therapies for the treatment of cancer. Raisedfunding over 2 rounds from 4 investors. Founded by Jin Zhang in the year 2021. CellOrigin has 438 competitors.See details»
原能细胞官网-富有社会责任感的企业家-原能细胞官网-富有社会责 …
原能细胞科技集团由知名企业家瞿建国先生与上市公司开能健康（股票代码300272）于2014年7月共同发起成立。首期投资15亿元人民币，总部设立于张江科学城核心区域，拥有原能细胞产业 …See details»
Technology Platform_CellOrigin Technology (Hangzhou) Co., Ltd.
Technology Platform-CellOrigin Technology (Hangzhou) Co., Ltd. All categories . Technology Platform Categories: Product Technologies Time of issue: 2021-05-08 17:43:46 Views: 0See details»
Home | Cellular Origins
Introducing Constellation TM.. Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies (CGTs), has …See details»
Careers - Cellular Origins
2024 is a year of rapid growth for Cellular Origins – and you could join our mission to transform patient access to life-saving cell therapies. Cell therapies have shown the ability to cure the …See details»
Team - Cellular Origins
Stay up-to-date with Cellular Origins and our modular factory automation for cell and gene therapies. Your name Your email. As a TTP Company, the expertise within Cellular Origins …See details»
Talent Recruitment_CellOrigin Technology (Hangzhou) Co., Ltd.
Talent Recruitment-CellOrigin Technology (Hangzhou) Co., Ltd. 【Drug Registration Manager】 Description of job: 1. Develop an application plan and complete the registration and application …See details»
Protocells emerge in experiment simulating lifeless world: ‘There is …
3 days ago Kepa Ruiz Mirazo, a philosopher of biology and expert in the origin of life and protocellular models, also applauds García Ruiz’s “excellent work.” “The significance of this …See details»
CellOrigin Biotech secured a new round of investment for its ...
Origin: Time of issue: 2021-07-20 12:18; Views: Information . On July 15th, CellOrigin Biotech, a company committed to iPSC-derived innate immune cell therapeutics, has announced a new …See details»